2-hydroxy-5-iodo-4,6-dimethylpyridine-3-carbonitrile, 95.0%, 250mg

(S)-(-)-Butylene Oxide>98.0%(GC)5mL

(2r,3r,5r,6r,7r,8r)-Cubane-1-carboxylic Acid>98.0%(GC)(qNMR)100mg

Methyl(3r)-1-[(2,4-dimethoxyphenyl)methyl]-5-oxo-pyrrolidine-3-carboxylate, 98%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 1.00 µm, 1 Piece(s)

(2S,5S)-1-(2-(1,3-Dioxolan-2-yl)phenyl)-2,5-diethylphospholane, 98%, 1g

5-METHOXY-3-(PYRROLIDIN-1-YLMETHYL)-1H-INDOLE, 95.0%, 5g

(R)-2-Amino-3-(2-iodophenyl)propanoic acid, 95.0%, 1g

Propan-2-yl 3-bromo-4-chloro-5-methylbenzoate, 98%, 1g

n-(Pyridin-2-yl)benzamide, 98%, 10g

5-BROMOPYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE, 95.0%, 5g

2-(4-Methylphenylsulfonamido)-3-phenylpropanoic acid, 97%, 5g

7-(trifluoromethyl)-1,4-dihydroquinoline-4-thione, 97%, 100mg